Skip to Main Content

File this under “What were they thinking?”

For the second time this year, Pfizer has made substantial price hikes on some of its medicines, a move that disregards blistering criticism of the pharmaceutical industry over the cost of prescription drugs.

advertisement

Specifically, the drug maker raised prices for 91 medicines on June 1 by between 5 percent and 13 percent, according to The Financial Times. This marks the second time this year that Pfizer boosted prices and, when factoring in price hikes made last January, the company has raised prices an average of 20 per cent this year.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

Comments are closed.